Literature DB >> 18851833

Substrate-assisted catalysis by PARP10 limits its activity to mono-ADP-ribosylation.

Henning Kleine1, Elzbieta Poreba, Krzysztof Lesniewicz, Paul O Hassa, Michael O Hottiger, David W Litchfield, Brian H Shilton, Bernhard Lüscher.   

Abstract

ADP-ribosylation controls many processes, including transcription, DNA repair, and bacterial toxicity. ADP-ribosyltransferases and poly-ADP-ribose polymerases (PARPs) catalyze mono- and poly-ADP-ribosylation, respectively, and depend on a highly conserved glutamate residue in the active center for catalysis. However, there is an apparent absence of this glutamate for the recently described PARP6-PARP16, raising questions about how these enzymes function. We find that PARP10, in contrast to PARP1, lacks the catalytic glutamate and has transferase rather than polymerase activity. Despite this fundamental difference, PARP10 also modifies acidic residues. Consequently, we propose an alternative catalytic mechanism for PARP10 compared to PARP1 in which the acidic target residue of the substrate functionally substitutes for the catalytic glutamate by using substrate-assisted catalysis to transfer ADP-ribose. This mechanism explains why the novel PARPs are unable to function as polymerases. This discovery will help to illuminate the different biological functions of mono- versus poly-ADP-ribosylation in cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18851833     DOI: 10.1016/j.molcel.2008.08.009

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  146 in total

1.  Crystal structure of human ADP-ribose transferase ARTD15/PARP16 reveals a novel putative regulatory domain.

Authors:  Tobias Karlberg; Ann-Gerd Thorsell; Åsa Kallas; Herwig Schüler
Journal:  J Biol Chem       Date:  2012-06-01       Impact factor: 5.157

2.  Profiling PARP inhibitors.

Authors:  Philip Jones
Journal:  Nat Biotechnol       Date:  2012-03-07       Impact factor: 54.908

3.  Identification of a regulatory segment of poly(ADP-ribose) glycohydrolase.

Authors:  Davide Botta; Myron K Jacobson
Journal:  Biochemistry       Date:  2010-09-07       Impact factor: 3.162

4.  Battle between influenza A virus and a newly identified antiviral activity of the PARP-containing ZAPL protein.

Authors:  Chien-Hung Liu; Ligang Zhou; Guifang Chen; Robert M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-26       Impact factor: 11.205

5.  Tracking Effects of SIL1 Increase: Taking a Closer Look Beyond the Consequences of Elevated Expression Level.

Authors:  Thomas Labisch; Stephan Buchkremer; Vietxuan Phan; Laxmikanth Kollipara; Christian Gatz; Chris Lentz; Kay Nolte; Jörg Vervoorts; José Andrés González Coraspe; Albert Sickmann; Stephanie Carr; René P Zahedi; Joachim Weis; Andreas Roos
Journal:  Mol Neurobiol       Date:  2017-04-11       Impact factor: 5.590

6.  Poly(ADP-ribose) regulates post-transcriptional gene regulation in the cytoplasm.

Authors:  Anthony Leung; Tanya Todorova; Yoshinari Ando; Paul Chang
Journal:  RNA Biol       Date:  2012-05-01       Impact factor: 4.652

7.  Combining affinity purification by ADP-ribose-binding macro domains with mass spectrometry to define the mammalian ADP-ribosyl proteome.

Authors:  Nadia Dani; Annalisa Stilla; Adriano Marchegiani; Antonio Tamburro; Susanne Till; Andreas G Ladurner; Daniela Corda; Maria Di Girolamo
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-25       Impact factor: 11.205

8.  PARP-3 is a mono-ADP-ribosylase that activates PARP-1 in the absence of DNA.

Authors:  Olga Loseva; Ann-Sofie Jemth; Helen E Bryant; Herwig Schüler; Lari Lehtiö; Tobias Karlberg; Thomas Helleday
Journal:  J Biol Chem       Date:  2010-01-11       Impact factor: 5.157

9.  Proteome-wide Analysis Reveals Substrates of E3 Ligase RNF146 Targeted for Degradation.

Authors:  Litong Nie; Chao Wang; Nan Li; Xu Feng; Namsoo Lee; Dan Su; Mengfan Tang; Fan Yao; Junjie Chen
Journal:  Mol Cell Proteomics       Date:  2020-09-21       Impact factor: 5.911

10.  PARP10 deficiency manifests by severe developmental delay and DNA repair defect.

Authors:  Maher Awni Shahrour; Claudia M Nicolae; Simon Edvardson; Motee Ashhab; Adri M Galvan; Daniel Constantin; Bassam Abu-Libdeh; George-Lucian Moldovan; Orly Elpeleg
Journal:  Neurogenetics       Date:  2016-09-13       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.